Stay updated on EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial page.

Latest updates to the EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedFooter text updated to Revision: v3.3.3 and the HHS Vulnerability Disclosure link was removed; no study data or content related to the trial is changed.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedThe version history now lists Revision: v3.3.2, replacing Revision: v3.2.0. This is a minor metadata update with no impact on study details.SummaryDifference0.0%

- Check50 days agoChange DetectedThe notice about a lapse in government funding and possible data update delays was removed from the page.SummaryDifference0.3%

- Check64 days agoChange DetectedNew history entries were added to the page, indicating updates to the study record such as status/contacts/locations. The core study details remain unchanged, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check93 days agoChange DetectedUpdated the page to add a government funding/operating-status notice and increment the version to v3.2.0, removing the previous v3.1.0 reference.SummaryDifference8%

- Check100 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. No other page content appears affected.SummaryDifference0.2%

Stay in the know with updates to EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial page.